AstraZeneca sells rights for Atacand to Cheplapharm
AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in Europe...
NanoGenics acquired to advance gene therapy
The Scottish Biotech company Ryboquin, announces the acquisition of Nanogenic Solutions, to form a new product and platform company, Nanogenics Limited. The combined company,...
EUSA Pharma announce acquisition of SYLVANT® from Janssen
EUSA Pharma acquires SYLVANT from Janssen for $115 million
BioIVT acquires Optivia Biotechnology
BioIVT, a provider of research models and services for drug development, has announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its...
Sanofi and Advent finalise negotiations for the acquisition of Zentiva
Sanofi and Advent International (Advent) have finished negotiations for the acquisition of Zentiva - Sanofi's European generics business. Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion...
Takeda ups bid to $65 billion in negotiations to buy Shire
Takeda has increased offer to buy Shire for a mix of stock and cash worth ~$65 billion
Merck to sell Consumer Health to Procter & Gamble
Merck has sold its global Consumer Health business to Procter & Gamble
Advent in negotiations to acquire Sanofi’s generics business
Advent and Sanofi are in negotiations under which Advent would acquire Zentiva,
Certara acquires Analytica Laser
Certara announced it has acquired Analytica Laser which uses health economics and outcomes research (HEOR)
Mylan partners with Fujifilm Kyowa Kirin Biologics
Mylan partners with Fujifilm Kyowa Kirin Biologics to commercialise a biosimilar to Humira®
Latest articles
Bayer acquires AskBio to broaden cell and gene therapy innovation
Bayer AG has announced the acquisition of Asklepios BioPharmaceutical, Inc, AskBio, a US-headquartered biopharmaceutical company specialised in the research, development and manufacturing of gene...
Evrysdi™ approved for the treatment of spinal muscular atrophy
PTC Therapeutics, Inc. have announced that Evrysdi™ (risdiplam) has been approved in Brazil by the National Health Surveillance Agency (ANVISA) for the treatment of...
The importance of security for medical device firms
With news hitting the headlines that global pharmaceutical company Pfizer Inc. has suffered a huge data breach and in light of National Cyber Security...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Pfizer suffers huge data breach on unsecured cloud storage
Global pharmaceutical giant Pfizer Inc. has suffered a huge data breach, with patient information found exposed on unsecured cloud storage. The exposed data was...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
ViiV Healthcare receives positive CHMP for treatment of HIV
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorisation for...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...